News & Updates

Several studies presented at ACOG 2022 have raised the question as to whether postpartum depression (PPD) is one of the mental health outcomes of the COVID-19 pandemic.

Ixazomib-dexamethasone (ixa-dex) and pomalidomide-dexamethasone (pom-dex) achieve comparable levels of efficacy and safety in relapsed and refractory multiple myeloma (RRMM) patients who had already been exposed to prior lenalidomide-based regimens, a recent study has found.

Electroconvulsive therapy (ECT) or the delivery of a finely controlled electric current to the brain in patients with schizophrenia can effectively address negative symptoms, which in turn translates to improvements in overall function, as shown in a study from Singapore.

Remote insulin pump training among young patients with type 1 diabetes (T1D) appears to be as safe as in-person training, suggest the results of a recent study.

Alcohols and alcohol-based disinfectants are not strong enough to eliminate the hepatitis E virus (HEV), except for one commercial ethanol-based product that has phosphoric acid, a study has shown. This finding may help develop measures to reduce transmission in clinical practice.

Use of an antihypertensive drug does not appear to reduce the risk of all-cause mortality or hospital readmission in hospitalized older patients with heart failure with reduced ejection fraction (HFrEF) who are receiving contemporary treatments for HF, reveals a recent study.

In patients with non-small-cell lung cancer (NSCLC), image-guided thermal ablation (IGTA) via microwave ablation (MWA) appears to deliver better survival benefit compared with another IGTA subtype, radiofrequency ablation (RFA), or stereotactic body radiation therapy (SBRT), according to a systematic review and meta-analysis presented at ATS 2022.